Explore more publications!

Healthcare Focus Minnesota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Focus Minnesota.

Press releases published on October 28, 2025

Former Amazon Care Executive Dr. Sunita Mishra Joins Heald’s Advisory Board to Accelerate Expansion Across Employers and Provider Networks
Remedy's Nutrition® Launches Premium Horse Chestnut 1000mg Capsules to Support Vein Health and Healthy Circulation
Incorporating Universal Screening and School Based Mental Health Initiatives in the Classroom
HealthPRO Canada Earns Great Place to Work® Certification for Fourth Consecutive Year
Trethera Successfully Completes Phase 1 Dose Escalation Trial Demonstrating Broad Therapeutic Window, Favorable Safety, and Confirmed Target Engagement
Step Therapy Shifts and Pipeline Momentum Reshape the Membranous Nephropathy Treatment Landscape, according to Spherix Global Insights
Longeveron® to Report Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
Assertio Announces Leadership Transition
New Study Finds Online Tinnitus Course “Still Tinnitus” Effective
Cult-Favorite Mediterranean Lifestyle Brand Launches High-Phenolic Extra Virgin Olive Oil Shot
Olympia Pharmaceuticals Strengthens National Presence, Bringing New Licensing to Mississippi
Sevaro Health Named to the 2025 CB Insights’ List of the 50 Most Promising Digital Health Startups
His Highness Sheikh Nahyan bin Zayed Al Nahyan Assumes Executive Chairmanship of NeOnc Technologies' Subsidiary, NuroMENA, Pioneering UAE-US Partnership in Brain Cancer Treatment
Sharecare awarded three-year NCQA Accreditation for Wellness and Health Promotion
Avance Clinical Unveils Dedicated CNS Center of Excellence for Expert Clinical Trial Services in Neuroscience
Palisade Bio Appoints Sharon Skare as Vice President, Global Head of Clinical Operations
Little Leaves Behavioral Services Continues Strategic Expansion With Two New ABA Therapy Centers in Virginia
Quoin Pharmaceuticals Announces Recruitment of Three Additional Patients in Investigator Pediatric Netherton Syndrome Study and Provides Positive 9 month ‘Whole Body’ Data Update from Ongoing Study
Profusa Completes Manufacturing Build-Out, On Track to Begin Product Shipments and Revenue in Early 2026
Lantheus Announces FDA Acceptance of New Drug Application for MK-6240, a PET Imaging Agent Targeting Tau in Alzheimer’s Disease

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions